The Alfred's Director of Anaesthesia and Perioperative Medicine, Professor Paul Myles, and his team were today awarded Australian Trial of the Year for their worldwide study exploring the risks associated with aspirin and Tranexamic acid (TXA).
Minister for Health, the Hon Greg Hunt MP, officially announced the award at today’s Clinical Trials 2017: National Tribute & Awards Ceremony.
The awards, which formed part of celebrations marking International Clinical Trials Day, recognises remarkable Australians who make ground-breaking clinical trials.
Congratulations to Prof Paul Myles and his team for the well-earned award and congratulations also to those who were nominated.
The study, led by The Alfred and Monash University, shows that TXA can nearly halve the number of people who suffer complications with bleeding following open heart and other major surgery.
TXA reduces the risk of serious bleeding complications by 40 per cent, resulting in fewer blood transfusions and emergency re-operations.